COMBOGESIC IV

Hikma Pharmaceuticals USA Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 15, 2023
Approval ID: be408a5a-48e4-43c0-9cb1-bbf830b54f5b
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use COMBOGESIC IV safely and effectively. See full prescribing information for COMBOGESIC IV. COMBOGESIC IV (acetaminophen and ibuprofen) injection for intravenous use Initial U.S. Approval: 2023

Quick Stats

Total Products1

Labelers2

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.